Cholangiocarcinoma

Cholangiocarcinoma (CCA) is a biliary tract cancer (BTC, see this term) originating in the epithelium of the biliary tree, either intra or extra hepatic.

Diabetes mellitus

A group of abnormalities characterized by hyperglycemia and glucose intolerance.


Total: 5

                       


(per page)
PMID (PMCID)
28877632
 FEMALE
Case report: pembrolizumab-induced Type 1 diabetes in a patient with metastatic cholangiocarcinoma.
Smith-Cohn MA, Gill D, Voorhies BN, Agarwal N, Garrido-Laguna I.
Immunotherapy. 2017;9(10):797-804.
Aftereight cycles, she developed new onset type 1 diabetes mellitus with positive glutamic acid decarboxylase antibody titers.Conclusions:To our knowledge, this is the first reported case of PD-1 inhibitor associated Type 1 diabetes mellitus in a patient with cholangiocarcinoma and supports others' experiences that PD-1 inhibition can cause a spectrum of autoimmune adverse events that require clinical monitoring and periodic screenings.
28877632
 FEMALE
Case report: pembrolizumab-induced Type 1 diabetes in a patient with metastatic cholangiocarcinoma.
Smith-Cohn MA, Gill D, Voorhies BN, Agarwal N, Garrido-Laguna I.
Immunotherapy. 2017;9(10):797-804.
Aftereight cycles, she developed new onset type 1 diabetes mellitus with positive glutamic acid decarboxylase antibody titers.Conclusions:To our knowledge, this is the first reported case of PD-1 inhibitor associated Type 1 diabetes mellitus in a patient with cholangiocarcinoma and supports others' experiences that PD-1 inhibition can cause a spectrum of autoimmune adverse events that require clinical monitoring and periodic screenings.
25400186
 MALE
IgA-dominant postinfectious glomerulonephritis associated with Escherichia coli infection caused by cholangitis.
Kikuchi H, Aoyagi M, Nagahama K, Yamamura C, Arai Y, Hirasawa S, Aki S, Inaba N, Tanaka H, Tamura T.
Intern Med. 2014;53(22):2619-24.
A 76-year-old man with a history of type 2 diabetes mellitus was admitted with cholangitis caused by cholangiocarcinoma.
15760789
 FEMALE
Diabetes mellitus as the presenting feature of extrahepatic cholangiocarcinoma in situ: case report and review of literature.
Costa DB, Chen AA, Marginean EC, Inzucchi SE.
Endocr Pract. 2004;10(5):417-23.
Diabetes mellitus as the presenting feature of extrahepatic cholangiocarcinoma in situ: case report and review of literature.
15760789
 FEMALE
Diabetes mellitus as the presenting feature of extrahepatic cholangiocarcinoma in situ: case report and review of literature.
Costa DB, Chen AA, Marginean EC, Inzucchi SE.
Endocr Pract. 2004;10(5):417-23.
A review of the literature involving cholangiocarcinoma, pancreatic tumors, and diabetes mellitus is also presented.